반응식
I[C:2]1[CH:7]=[CH:6][C:5]([C:8]2[O:9][C:10]([CH3:13])=[N:11][N:12]=2)=[CH:4][CH:3]=1.[CH3:14][C:15]1[CH:35]=[CH:34][C:18]([C:19]([NH:21][C:22]2[CH:27]=[CH:26][CH:25]=[C:24]([N:28]3[CH2:33][CH2:32][O:31][CH2:30][CH2:29]3)[CH:23]=2)=[O:20])=[CH:17][C:16]=1B1OC(C)(C)C(C)(C)O1>CC(O)C>[N:28]1([C:24]2[CH:23]=[C:22]([NH:21][C:19]([C:18]3[CH:34]=[C:35]([C:2]4[CH:7]=[CH:6][C:5]([C:8]5[O:9][C:10]([CH3:13])=[N:11][N:12]=5)=[CH:4][CH:3]=4)[C:15]([CH3:14])=[CH:16][CH:17]=3)=[O:20])[CH:27]=[CH:26][CH:25]=2)[CH2:29][CH2:30][O:31][CH2:32][CH2:33]1참가 물질
4
반응물 2
생성물 1
시약·촉매·용매 1
실험 절차
Example 36 was prepared using 2-(4-iodophenyl)-5-methyl-[1,3,4]oxadiazole (Intermediate 15) and 4-methyl-N-(3-morpholin-4-phenyl)-3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzamide (Intermediate 5) with propan-2-ol as the solvent.
후처리
- customExample 36 was prepared
출처 및 근거
- ORD 기록
- ord-a4b8d48e0080424d84f52a79d258df2c
- 출처 데이터셋
- uspto-grants-2008_09
- 특허 번호
- US07425555B2
연결된 노트
불러오는 중…